Although 80% of melanoma tumors retain non-mutated, wild-type TP53 expression [5], TP53 fails to function as a tumor suppressor in melanoma cells, and reduced levels of p53 contribute to aggressiveness and resistance to therapy. This evidence concerns the gene TP53 and melanoma.